Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells

Molecular and Cellular Biology

Volumn 15, Issue 12, 1995, Pages 6710-6719

  Krishnan, Venkatesh ^a   Porter, Weston ^a   Santostefano, Michael ^a   Wang, Xiahong ^a   Safe, Stephen ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ALKALINE PHOSPHATASE; ANTISENSE OLIGONUCLEOTIDE; AROMATIC HYDROCARBON RECEPTOR; BROXURIDINE; CATHEPSIN D; CHLORAMPHENICOL ACETYLTRANSFERASE; ESTROGEN; ESTROGEN RECEPTOR; MESSENGER RNA; TRANSCRIPTION FACTOR SP1;

ANIMAL CELL; ARTICLE; BREAST CANCER; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; RABBIT; REPORTER GENE; RETICULOCYTE LYSATE; XENOBIOTIC METABOLISM;

ANIMALIA; MINK CELL FOCUS-FORMING VIRUS; ORYCTOLAGUS CUNICULUS;

EID: 0028884592     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.15.12.6710     Document Type: Article

References (86)

1. Asman, D. C., K. Takimoto, H. C. Pitot, T. J. Dunn, and R. Lindahl. 1993. Organization and characterization of the rat class 3 aldehyde dehydrogenase gene. J. Biol. Chem. 268:12530-12536.
2. Astroff, B., B. Eldridge, and S. Safe. 1991. Inhibition of 17β-estradiol-induced and constitutive expression of the cellular protooncogene c-fos by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the female uterus. Toxicol. Lett. 56:305-315.
3. Astroff, B., C. Rowlands, R. Dickerson, and S. Safe. 1990. 2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibition of 17β-estradiol-induced increases in rat uterine EGF receptor binding activity and gene expression. Mol. Cell. Endocrinol. 72:247-252.
4. Augereau, P., F. Miralles, V. Cavailles, and C. Gaudelet. 1994. Characterization of the proximal estrogen-responsive element of human cathepsin D gene. Mol. Endocrinol. 8:693-703.
5. Berger, J., J. Hauber, R. Gieger, and B. R. Cullen. 1988. Secreted alkaline phosphatase: a novel reporter gene with unique applications. Gene 66:1-10.
6. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
7. Burbach, K. M., A. B. Poland, and C. A. Bradfield. 1992. Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc. Natl. Acad. Sci. USA 89:8185-8189.
8. Cavailles, V., P. Augereau, M. Garcia, and H. Rochefort. 1988. Estrogens and growth factors induce mRNA of the 52K-pro-cathepsin-D secreted by breast cancer cells. Nucleic Acids Res. 16:1903-1919.
9. Cavailles, V., P. Augereau, and H. Rochefort. 1991. Cathepsin D gene of human MCF-7 cells contains estrogen-responsive sequences in its 5′-proximal flanking region. Biochem. Biophys. Res. Commun. 174:816-824.
10. Cavailles, V., P. Augereau, and H. Rochefort. 1993. Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription. Proc. Natl. Acad. Sci. USA 90:203-207.
11. Cavailles, V., M. Garcia, and H. Rochefort. 1989. Regulation of cathepsin D and pS2 gene expression by growth factors in MCF-7 human breast cancer cells. Mol. Endocrinol. 3:552-558.
12. Chomczynski, P., and N. Sacchi. 1987. Single step method of RNA isolation by acid guanidium thiocyanatephenol-chloroform extraction. Anal. Biochem. 162:156-159.
13. Cuthill, S., A. Wilhelmsson, and L. Poellinger. 1991. Role of the ligand in intracellular receptor function: receptor affinity determines activation in vitro of the latent dioxin receptor to a DNA-binding form. Mol. Cell. Biol. 11:401-411.
14. Dauvois, S., P. S. Danielian, R. White, and M. G. Parker. 1992. Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover. Proc. Natl. Acad. Sci. USA 89:4037-4041.
15. Denison, M. S., J. M. Fisher, and J. P. Whitlock, Jr. 1988. Inducible, receptor-dependent protein-DNA interactions at a dioxin-responsive transcriptional enhancer. Proc. Natl. Acad. Sci. USA 85:2528-2532.
16. Denison, M. S., J. M. Fisher, and J. P. Whitlock, Jr. 1988. The DNA recognition site for the dioxin-Ah receptor complex. J. Biol. Chem. 263: 17221-17224.
17. Denison, M. S., H. I. Swanson, P. A. Bank, and E. V. Yao. 1994. Interaction of transformed Ah receptor complex with a dioxin-responsive element and modulation of gene expression. Toxicologist 14:238.
18. Dubik, D., and R. P. C. Shiu. 1992. Mechanism of estrogen activation of c-myc oncogene expression. Oncogene 7:1587-1594.
19. Elferink, C. J., T. A. Gasiewcz, and J. P. Whitlock, Jr. 1990. Protein-DNA interactions at a dioxin-responsive enhancer. Evidence that the transformed Ah receptor is heteromeric. J. Biol. Chem. 265:20708-20712.
20. 2 expression in a human keratinocyte cell line involves both transcriptional and post-transcriptional control. J. Biol. Chem. 267: 24591-24595.
21. Gallo, M. A., E. J. Hesse, G. J. MacDonald, and T. H. Umbreit. 1986. Interactive effects of estradiol and 2,3,7,8-tetrachlorodibenzo-p-dioxin on hepatic cytochrome P-450 and mouse uterus. Toxicol. Lett. 32:123-132.
22. Gierthy, J. F., J. A. Bennett, L. M. Bradley, and D. S. Cutler. 1993. Correlation of in vitro and in vivo growth suppression of MCF-7 human breast cancer by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Res. 53:3149-3153.
23. Gierthy, J. F., and D. W. Lincoln. 1988. Inhibition of postconfluent focus production in cultures of MCF-7 breast cancer cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Breast Cancer Res. 12:227-233.
24. Gierthy, J. F., D. W. Lincoln, M. B. Gillespie, J. I. Seeger, H. L. Martinez, H. W. Dickerman, and S.A. Kumar. 1987. Suppression of estrogen-regulated extracellular plasminogen activator activity of MCF-7 cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Res. 47:6198-6203.
25. Gierthy, J. F., D. W. Lincoln, K. E. Roth, S. S. Bowser, J. A. Bennett, L. Bradley, and H. W. Dickerman. 1991. Estrogen-stimulation of postconfluent cell accumulation and foci formation of human MCF-7 breast cancer cells. J. Cell. Biochem. 45:177-187.
26. Goldstein, J. A., and S. Safe. 1989. Mechanism of action and structure-activity relationships for the chlorinated dibenzo-p-dioxins and related compounds, p. 239-293. In R. D. Kimbrough and A. A. Jensen (ed.), Halogenated biphenyls. naphthalenes, dibenzodioxins and related compounds. Elsevier-North Holland, Amsterdam.
27. 1-450 gene. Nucleic Acids Res. 13:7269-7288.
28. Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044-1051.
29. Hankinson, O. 1993. Perspectives in biochemistry and biophysics: research on the aryl hydrocarbon (dioxin) receptor is primed to take off. Arch. Biochem. Biophys. 300:1-5.
30. Harper, N., X. Wang, H. Liu, and S. Safe. 1994. Inhibition of estrogen-induced progesterone receptor in MCF-7 human breast cancer cells by aryl hydrocarbon (Ah) receptor agonists. Mol. Cell. Endocrinol. 104:47-55.
31. Hoffman, E. C., H. Reyes, F. Chu, F. Sander, L. H. Conley, B. A. Brooks, and O. Hankinson. 1991. Cloning of a factor required for activity of the Ah (dioxin) receptor. Science 252:954-958.
32. Holcomb, M., and S. Safe. 1994. Inhibition of 7,12-dimethylbenzanthracene-induced rat mammary tumor growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Lett. 82:43-47.
33. Hudson, L. G., W. A. Toscano, Jr., and W. F. Greenlee. 1985. Regulation of epidermal growth factor binding in a human keratinocyte cell line by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 77:251-259.
34. 1-450 gene transcription by 2,3,7,8-tetrachlorodibenzo-p-dioxin in wild type and variant mouse hepatoma cells. J. Biol. Chem. 259:5400-5402.
35. Jaiswal, A. K. 1994. Human NAD(P)H:quinone oxidoreductase: gene structure, activity and tissue-specific expression. J. Biol. Chem. 269:14502-14508.
36. 1-450 inducers on the cell-surface receptors for epidermal growth factor, phorbol 12,13-dibutyrate, or insulin of cultured mouse hepatoma cells. J. Biol. Chem. 258:10378-10383.
37. Klein-Hitpass, L., M. Schorpp, U. Wagner, and G. U. Ryffel. 1986. An estrogen-responsive element derived from the 5′-flanking region of the xenopus vitellogenin A2 gene functions in transfected human cells. Cell 46: 1053-1061.
38. Kociba, R. J., D. G. Keyes, J. E. Beger, R. M. Carreon, C. E. Wade, D. A. Dittenber, R. P. Kalnins, L. E. Frauson, C. L. Park, S. D. Barnard, R. A. Hummel, and C. G. Humiston. 1978. Results of a 2-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats. Toxicol. Appl. Pharmacol. 46:279-303.
39. Krishnan, V., T. R. Narasimhan, and S. Safe. 1992. Development of gel staining techniques for detecting the secretion of procathepsin D (52-kDa protein) in MCF-7 human breast cancer cells. Anal. Biochem. 204:137-142.
40. Krishnan, V., and S. Safe. 1993. Polychlorinated biphenyls (PCBs), dibenzop-dioxins (PCDDs) and dibenzofurans (PCDFs) as antiestrogens in MCF-7 human breast cancer cells: quantitative structure-activity relationships. Toxicol. Appl. Pharmacol. 120:55-61.
41. Krishnan, V., X. Wang, and S. Safe. 1994. ER/Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells. J. Biol. Chem. 269:15912-15917.
42. Landers, J. P., and N. J. Bunce. 1991. The Ah receptor and the mechanism of dioxin toxicity. Biochem. J. 276:273-287.
43. Madhukar, B. V., D. W. Brewster, and F. Malsumura. 1984. Effects of in vivo-administered 2,3,7,8-tetrachlorodibenzo-p-dioxin on receptor binding of epidermal growth factor in the hepatic plasma membrane of rat, guinea pig, mouse, and hamster. Proc. Natl. Acad. Sci. USA 81:7407-7411.
44. Manchester, D. K., S. K. Gordon, C. L. Golas, E. A. Roberts, and A. B. Okey. 1987. Ah receptor in human placenta: stabilization by molybdate and characterization of binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin, 3-methylcholanthrene, and benzo[a]pyrene. Cancer Res. 47:4861-4868.
45. Marzluff, W. F. 1978. Transcription of RNA in isolated nuclei. Methods Cell Biol. 19:317-331.
46. May, F. E. B., D. J. Smith, and B. R. Westley. 1993. The human cathepsin D-encoding gene is transcribed from an estrogen-regulated and a constitutive start point. Gene 134:277-282.
47. May, F. E. B., and B. R. Westley. 1987. Effects of tamoxifen and 4-hydroxytamoxifen on the pNR-1 and pNR-2 estrogen regulated RNAs in human breast cancer cells. J. Biol. Chem. 262:15894-15899.
48. McGuire, J., M. L. Whitelaw, I. Pongratz, J.-Å. Gustafsson, and L. Poellinger. 1994. A cellular factor stimulates ligand-dependent release of hsp90 from the basic helix-loop-helix dioxin receptor. Mol. Cell. Biol. 14:2438-2446.
49. Merchant, M., V. Krishnan, and S. Safe. 1993. Mechanism of action of α-naphthoflavone as an Ah receptor antagonist in MCF-7 human breast cancer cells. Toxicol. Appl. Pharmacol. 120:179-185.
50. Miller, A. G., D. Israel, and J. P. Whitlock, Jr. 1983. Biochemical and genetic analysis of variant mouse hepatoma cells defective in the induction of benzo[a]pyrene-metabolizing enzyme activity. J. Biol. Chem. 258:3523-3527.
51. R) human breast cancer cells: a unique aryl hydrocarbon (Ah)-nonresponsive clone. J. Biol. Chem. 269:11751-11759.
52. Morisset, M., F. Capony, and H. Rochefort. 1986. Processing and estrogen regulation of the 52-kDa protein inside MCF-7 breast cancer cells. Endocrinology 119:2773-2782.
53. Nebert, D. W., D. D. Petersen, and A. Puga. 1991. Human AH locus polymorphism and cancer: inducibility of CYP1A1 and other genes by combustion products and dioxin. Pharmacogenetics 1:68-78.
54. Okey, A. B., D. S. Riddick, and P. A. Harper. 1994. The Ah receptor: mediator of the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds. Toxicol. Lett. 70:1-22.
55. Perdew, G. H. 1988. Association of the Ah receptor with the 90-kDa heat shock protein. J. Biol. Chem. 263:13802-13805.
56. Pimentai, R. A., B. Liang, G. K. Yee, A. Wilhelmsson, L. Poellinger, and K. E. Paulson. 1993. Dioxin receptor and C/EBP regulate the function of the glutathione S-transferase Ya gene xenobiotic response element. Mol. Cell. Biol. 13:4365-4373.
57. Piskorska-Pliszczynska, J., B. Keys, S. Safe, and M. S. Newman. 1986. The cytosolic receptor binding affinities and AHH induction potencies of 29 polynuclear aromatic hydrocarbons. Toxicol. Lett. 34:67-74.
58. Poland, A., E. Glover, and A. S. Kende. 1976. Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol: evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase. J. Biol. Chem. 251:4936-4946.
59. Poland, A., and J. C. Knutson. 1982. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons. Examinations of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol. 22:517-554.
60. Pongratz, I., G. G. F. Mason, and L. Poellinger. 1992. Dual roles of the 90 kDa heat shock protein Hsp 90 in modulating functional activities of the dioxin receptor. J. Biol. Chem. 267:13728-13734.
61. Probst, M. R., S. Reisz-Porszasz, R. V. Agbunag, M. S. Ong, and O. Hankinson. 1993. Role of the aryl hydrocarbon receptor nuclear translocation protein in aryl hydrocarbon (dioxin) receptor action. Mol. Pharmacol. 44:511-518.
62. Quattrochi, L. C., and R. H. Tukey. 1989. The human cytochrome CYP1A2 gene contains regulatory elements responsive to 3-methylcholanthrene. Mol. Pharmacol. 36:66-71.
63. Redecker, B., B. Heckendorf, H. Grosch, G. Mersmann, and A. Hasilik. 1991. Molecular organization of the human cathepsin D gene. DNA Cell Biol. 10:423-431.
64. Rushmore, T. H., R. G. King, K. E. Paulson, and C. B. Pickett. 1990. Regulation of glutathione S-transferase Ya subunit gene expression: identification of a unique xenobiotic-responsive element controlling inductible expression by planar aromatic compounds. Proc. Natl. Acad. Sci. USA 87: 3826-3830.
65. Safe, S. 1988. The aryl hydrocarbon (Ah) receptor. ISI atlas of science. Pharmacology 2:78-83.
66. Safe, S., B. Astroff, M. Harris, T. Zacharewski, R. Dickerson, M. Romkes, and L. Biegel. 1991. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and related compounds as antiestrogens: characterization and mechanism of action. Pharmacol. Toxicol. 69:400-409.
67. Safe, S., S. Bandiera, T. Sawyer, B. Zmudzka, G. Mason, M. Romkes, M. A. Denomme, J. Sparling, A. B. Okey, and T. Fujita. 1985. Effects of structure on binding to the 2,3,7,8-TCDD receptor protein and AHH induction - halogenated biphenyls. Environ. Health Perspect. 61:21-33.
68. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
69. Savouret, J. F., A. Bailly, M. Misrahi, C. Rarch, G. Redeuilh, A. Chauchereau, and E. Milgram. 1991. Characterization of the hormone responsive element involved in the regulation of the progesterone receptor gene. EMBO J. 10:1875-1883.
70. Sogawa, K., A. Fujisawa-Sehara, M. Yamane, and Y. Fujii-Kuriyama. 1986. Location of regulatory elements responsible for drug induction in the rat cytochrome P-450c gene. Proc. Natl. Acad. Sci. USA 83:8044-8048.
71. Spyratos, R., J. Brouillet, A. DeFrenne, K. Hacene, J. Rouesse, T. Maudelande, M. Brunet, C. Andrieu, A. Desplaces, and H. Rochefort. 1989. Cathepsin D: an independent prognostic factor for metastasis of breast cancer. Lancet ii:115-118.
72. Stahl, B. U., D. G. Beer, L. W. D. Weber, and K. Rozman. 1993. Reduction of hepatic phosphoenolpyruvate carboxykinase (PEPCK) activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is due to decreased mRNA levels. Toxicology 79:81-95.
73. Swanson, H. I., and C. A. Bradfield. 1993. The Ah-receptor: genetics, structure and function. Pharmacogenetics 3:213-223.
74. Tandon, A. K., G. M. Clark, G. C. Chamness, J. M. Chirgwin, and W. L. McGuire. 1990. Cathepsin D and prognosis in breast cancer. N. Engl. J. Med. 322:297-302.
75. Thorpe, S. M., H. Rochefort, M. Garcia, G. Freiss, I. J. Christensen, S. Khalaf, F. Paolucci, B. Pau, R. B. Rasmussen, and C. Rose. 1989. Association between high concentration of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer. Cancer Res. 49:6008-6014.
76. Wakeling, A. E. 1991. Steroidal pure antiestrogens, p. 239-257. In M. E. Lippman and R. B. Dickson (ed.), Regulatory mechanisms in breast cancer. Kluwer, Boston.
77. Wang, X., T. R. Narasimhan, V. Morrison, and S. Safe. 1991. In situ and in vitro photoaffinity labeling of the nuclear aryl hydrocarbon (Ah) receptor from transformed rodent and human cell lines. Arch. Biochem. Biophys. 287:186-194.
78. Wang, X., J. S. Thomsen, M. Santostefano, R. Rosengren, S. Safe, and G. H. Perdew. Comparative properties of the nuclear Ah receptor complex from several human cell lines. Eur. J. Pharmacol., in press.
79. Westley, B., F. E. B. May, A. M. C. Brown, A. Krust, P. Chambon, M. E. Lippman, and H. Rochefort. 1984. Effects of antiestrogens on the estrogen regulated pS2 RNA, 51 and 160 K proteins in MCF-7 and two tamoxifen-resistant sublines. J. Biol. Chem. 259:10030-10035.
80. Westley, B. R., F. Holzel, and F. E. B. May. 1989. Effects of oestrogen and the antioestrogens tamoxifen and LY117018 on four oestrogen-regulated RNAs in the EFM-19 breast cancer cell line. J. Steroid Biochem. 32:365-372.
81. Westley, B. R., and F. E. B. May. 1987. Oestrogen regulates cathepsin D mRNA levels in oestrogen responsive human breast cancer cells. Nucleic Acids Res. 15:3773-3780.
82. Whitlock, J. P., Jr. 1993. Mechanistic aspects of dioxin action. Chem. Res. Toxicol. 6:754-763.
83. 1-450 gene expression in mouse hepatoma cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Drug Metab. Rev. 20:839-846.
84. Wu-Peng, X. S., T. E. Pugliese, H. W. Dickerson, and B. T. Pentecost. 1992. Delineation of sites mediating estrogen regulation of the rat creatine kinase B gene. Mol. Endocrinol. 6:231-240.
85. Zacharewski, T. Personal communication.
86. Zacharewski, T., K. Bondy, P. McDonell, and Z. F. Wu. 1994. Antiestrogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17β-estradiol-induced pS2 expression. Cancer Res. 54:2707-2713.